EGFR and neoplasm: In response to EGFR CAR-T cell activation and IFN-γ secretion, the tumor cells upregulated the expression of the intercellular adhesion molecule-1 (ICAM-1), which in turn enabled the progressive entry of EGFR CAR-T cells from the periphery to the center of tumor islets [39].